Growth inhibition of Candida albicans by human vaginal epithelial cells

被引:56
作者
Barousse, MM
Steele, C
Dunlap, K
Espinosa, T
Boikov, D
Sobel, JD
Fidel, PL [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Obstet & Gynecol, New Orleans, LA 70112 USA
[3] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA
关键词
D O I
10.1086/324532
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vulvovaginal candidiasis (VVC) is a common mucosal infection caused by Candida species in women of childbearing age. Although acute VVC affects a large number of women and is often precipitated by hormonal fluctuations involving high estrogen levels, recurrent VVC (RVVC) affects another 5%-10% of women without any known predisposing factors. We have recently reported that vaginal epithelial cells from nonhuman primates and mice inhibit the growth of Candida albicans in vitro, which may represent an innate host defense mechanism against C. albicans at the vaginal mucosa. In the present study, we show that vaginal epithelial cells collected from healthy women with no history of VVC also exhibit anti-Candida activity, with no differences in activity at various stages of the menstrual cycle. Women diagnosed with RVVC, on the other hand, have reduced epithelial cell anti-Candida activity. These results are further evidence that vaginal epithelial cells provide an innate host resistance mechanism against Candida and that reduced activity may contribute to RVVC.
引用
收藏
页码:1489 / 1493
页数:5
相关论文
共 15 条
[1]  
DJEU JY, 1987, J IMMUNOL, V139, P2761
[2]   Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins [J].
Fichorova, RN ;
Rheinwald, JG ;
Anderson, DJ .
BIOLOGY OF REPRODUCTION, 1997, 57 (04) :847-855
[3]  
Fidel Paul L. Jr., 1999, Revista Iberoamericana de Micologia, V16, P8
[4]   Immunopathogenesis of recurrent vulvovaginal candidiasis [J].
Fidel, PL ;
Sobel, JD .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (03) :335-+
[5]   Analysis of vaginal cell populations during experimental vaginal candidiasis [J].
Fidel, PL ;
Luo, W ;
Steele, C ;
Chabain, J ;
Baker, M ;
Wormley, F .
INFECTION AND IMMUNITY, 1999, 67 (06) :3135-3140
[6]   A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection [J].
Han, YM ;
Morrison, RP ;
Cutler, JE .
INFECTION AND IMMUNITY, 1998, 66 (12) :5771-5776
[7]   HUMORAL IMMUNITY IN VAGINAL CANDIDIASIS [J].
MATHUR, S ;
VIRELLA, G ;
KOISTINEN, J ;
HORGER, EO ;
MAHVI, TA ;
FUDENBERG, HH .
INFECTION AND IMMUNITY, 1977, 15 (01) :287-294
[8]  
ODDS FC, 1988, CANDIDA CANDIDOSIS, P104
[9]   PATHOGENESIS AND TREATMENT OF RECURRENT VULVO-VAGINAL CANDIDIASIS [J].
SOBEL, JD .
CLINICAL INFECTIOUS DISEASES, 1992, 14 :S148-S153
[10]   Growth inhibition of Candida by human oral epithelial cells [J].
Steele, C ;
Leigh, J ;
Swoboda, R ;
Fidel, PL .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1479-1485